Skip to main content
External resource Amsterdam

Monkeypox self-diagnosis abilities, determinants of vaccination and self-isolation intention after diagnosis among MSM, the Netherlands, July 2022

The global epidemic of monkeypox, a zoonotic disease, has recently changed from infections predominantly following an interaction with animals, to human-to-human transmission [1,2]. The monkeypox epidemic in European countries is currently predominantly affecting men-who-have-sex-with-men (MSM) and the number of infections is still increasing [3,4]. In the Netherlands 1,025 cases have been reported as at 11 August 2022, the majority in Amsterdam. Given the spread of the disease, investigating self-diagnostic abilities, and vaccination and self-isolation intentions is relevant to tailor further public health responses.

We conducted an online survey among MSM using a cohort established in 2017 [5] (n = 257), along with recruitment of MSM on a gay online dating app (n = 137) in the first half of July 2022, before the start of targeted monkeypox vaccination in the Netherlands [6]. Of the included 394 MSM, 43% (n=171) were below the age of 45-years, 6% (n=22) were living with HIV and 66% (n=241) were currently using HIV pre-exposure prophylaxis (PrEP) (see supplementary materials S1 for the population characteristics by PrEP use status, and S2 for participants’ age distribution).

 

Photo by Matteus Silva

References:

  1. Bragazzi NL, Kong JD, Mahroum N, Tsigalou C, Khamisy-Farah R, Converti M, et al. Epidemiological trends and clinical features of the ongoing monkeypox epidemic: A preliminary pooled data analysis and literature review. J Med Virol. 2022;jmv.27931.  https://doi.org/10.1002/jmv.27931  PMID: 35692117 

  2. Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, et al. The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Negl Trop Dis. 2022;16(2):e0010141.  https://doi.org/10.1371/journal.pntd.0010141  PMID: 35148313 

  3. European Centre for Disease Prevention and Control (ECDC). Joint ECDC-WHO Regional Office for Europe Monkeypox Surveillance Bulletin. Stockholm: ECDC; 2022. Available from: https://monkeypoxreport.ecdc.europa.eu/.

  4. National Institute for Public Health and the Environment (RIVM). Monkeypox. Bilthoven: RIVM; 2022. Available from: https://www.rivm.nl/en/monkeypox.

  5. Van Dijk M, De Wit JBF, Guadamuz TE, Martinez JE, Jonas KJ. Quality of Sex Life and Perceived Sexual Pleasure of PrEP Users in the Netherlands. J Sex Res. 2022;59(3):303-8.  https://doi.org/10.1080/00224499.2021.1931653  PMID: 34128741 

  6. Public Health Service of Amsterdam (GGD-Amsterdam). Amsterdam start maandag 25 juli met vaccineren tegen monkeypox. Amsterdam: GGD Amsterdam; 2022. Available from: https://www.ggd.amsterdam.nl/nieuwsoverzicht/start-vaccineren-monkeypox/.

View all documents
Related resources